The biggest question mark for the Missouri Tigers entering 2025 is at the most cruical position. For the past three seasons, Brady Cook has been with the Tigers ...

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...

Amazon and Samsung are both offering a pretty sweet deal on the Galaxy Z Fold7, Galaxy Z Flip7, and Galaxy Z Flip7 FE, all of ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Kioxia is not messing around with its latest ultra high-capacity solid state drive (SSD) offerings for the enterprise, which ...

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

A woman has revealed she's been given months to live after suffering from symptoms she thought was related to weight loss ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...